Vis enkel innførsel

dc.contributor.authorBjarkø, Vera Vik
dc.contributor.authorHaug, Eirin Beate
dc.contributor.authorSørgjerd, Elin Pettersen
dc.contributor.authorStene, Lars Christian Mørch
dc.contributor.authorLopez-Doriga Ruiz, Paz
dc.contributor.authorBirkeland, Kåre Inge
dc.contributor.authorBerg, Tore Julsrud
dc.contributor.authorGulseth, Hanne Løvdal
dc.contributor.authorIversen, Marjolein M.
dc.contributor.authorLanghammer, Arnulf
dc.contributor.authorÅsvold, Bjørn Olav
dc.coverage.spatialNorwayen_US
dc.date.accessioned2022-10-10T08:27:00Z
dc.date.available2022-10-10T08:27:00Z
dc.date.created2022-04-10T17:00:24Z
dc.date.issued2022
dc.identifier.citationBjarkø, V. V., Haug, E. B., Sørgjerd, E. P., Stene, L. C., Ruiz, P. L. D., Birkeland, K. I., Berg, T. J., Gulseth, H. L., Iversen, M. M., Langhammer, A., & Åsvold, B. O. (2022). Undiagnosed diabetes: Prevalence and cardiovascular risk profile in a population‐based study of 52,856 individuals. The HUNT Study, Norway. Diabetic Medicine, 39(6).en_US
dc.identifier.issn0742-3071
dc.identifier.urihttps://hdl.handle.net/11250/3024935
dc.description.abstractAims We investigated the current extent of undiagnosed diabetes and prediabetes and their associated cardiovascular risk profile in a population-based study. Methods All residents aged ≥20 years in the Nord-Trøndelag region, Norway, were invited to the HUNT4 Survey in 2017–2019, and 54% attended. Diagnosed diabetes was self-reported, and in those reporting no diabetes HbA1c was used to classify undiagnosed diabetes (≥48 mmol/mol [6.5%]) and prediabetes (39–47 mmol/mol [5.7%–6.4%]). We estimated the age- and sex-standardized prevalence of these conditions and their age- and sex-adjusted associations with other cardiovascular risk factors. Results Among 52,856 participants, the prevalence of diabetes was 6.0% (95% CI 5.8, 6.2), of which 11.1% were previously undiagnosed (95% CI 10.1, 12.2). The prevalence of prediabetes was 6.4% (95% CI 6.2, 6.6). Among participants with undiagnosed diabetes, 58% had HbA1c of 48–53 mmol/mol (6.5%–7.0%), and only 14% (i.e., 0.1% of the total study population) had HbA1c >64 mmol/mol (8.0%). Compared with normoglycaemic participants, those with undiagnosed diabetes or prediabetes had higher body mass index, waist circumference, systolic blood pressure, triglycerides and C-reactive protein but lower low-density lipoprotein cholesterol (all p < 0.001). Participants with undiagnosed diabetes had less favourable values for every measured risk factor compared with those with diagnosed diabetes. Conclusions The low prevalence of undiagnosed diabetes suggests that the current case-finding-based diagnostic practice is well-functioning. Few participants with undiagnosed diabetes had very high HbA1c levels indicating severe hyperglycaemia. Nonetheless, participants with undiagnosed diabetes had a poorer cardiovascular risk profile compared with participants with known or no diabetes.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.subjectdiabetes mellitusen_US
dc.subjectepidemiologyen_US
dc.subjectglycated haemoglobin Aen_US
dc.subjectheart disease risk factorsen_US
dc.subjectprediabetic stateen_US
dc.subjectprevalenceen_US
dc.subjectundiagnosed diseasesen_US
dc.titleUndiagnosed diabetes: Prevalence and cardiovascular risk profile in a population-based study of 52,856 individuals. The HUNT Study, Norwayen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2022 The Authorsen_US
dc.source.pagenumber1-11en_US
dc.source.volume39en_US
dc.source.journalDiabetic Medicineen_US
dc.source.issue6en_US
dc.identifier.doi10.1111/dme.14829
dc.identifier.cristin2016541
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal